Non-Stationary Outcome of Alternating Hemiplegia of Childhood into Adulthood.

ATP1A3 adult alternating hemiplegia of childhood movement disorders regression

Journal

Movement disorders clinical practice
ISSN: 2330-1619
Titre abrégé: Mov Disord Clin Pract
Pays: United States
ID NLM: 101630279

Informations de publication

Date de publication:
Feb 2022
Historique:
received: 01 09 2021
revised: 26 10 2021
accepted: 09 11 2021
entrez: 10 2 2022
pubmed: 11 2 2022
medline: 11 2 2022
Statut: epublish

Résumé

Although described as non-progressive, alternating hemiplegia of childhood (AHC) can display a sudden deterioration, anecdotally reported mainly in childhood. Outcome in adulthood is uncertain. Aim of this study is to describe the long-term follow-up of neurological function in adults with AHC. Seven adults with AHC were included in this retrospective single-center study. Clinical history and previous investigation data were gathered from the review of medical records. Video-documented neurological examination was performed at the last follow-up visit in four out of the seven reported indivisuals. Over a median follow-up of 16 years, neurological outcome and trajectories were heterogeneous. All individuals showed new neurological signs or symptoms. Three experienced a serious irreversible neurological deterioration after prolonged quadriplegic episodes and/or status epilepticus in their second or third decade. One patient died at age 29. This video-series suggests that AHC in adulthood is not stationary; larger cohorts are needed to identify genotype-phenotype correlations and clinically useful outcome predictors.

Sections du résumé

BACKGROUND BACKGROUND
Although described as non-progressive, alternating hemiplegia of childhood (AHC) can display a sudden deterioration, anecdotally reported mainly in childhood. Outcome in adulthood is uncertain.
OBJECTIVES OBJECTIVE
Aim of this study is to describe the long-term follow-up of neurological function in adults with AHC.
METHODS METHODS
Seven adults with AHC were included in this retrospective single-center study. Clinical history and previous investigation data were gathered from the review of medical records. Video-documented neurological examination was performed at the last follow-up visit in four out of the seven reported indivisuals.
RESULTS RESULTS
Over a median follow-up of 16 years, neurological outcome and trajectories were heterogeneous. All individuals showed new neurological signs or symptoms. Three experienced a serious irreversible neurological deterioration after prolonged quadriplegic episodes and/or status epilepticus in their second or third decade. One patient died at age 29.
CONCLUSIONS CONCLUSIONS
This video-series suggests that AHC in adulthood is not stationary; larger cohorts are needed to identify genotype-phenotype correlations and clinically useful outcome predictors.

Identifiants

pubmed: 35141355
doi: 10.1002/mdc3.13388
pii: MDC313388
pmc: PMC8810436
doi:

Types de publication

Journal Article

Langues

eng

Pagination

206-211

Informations de copyright

© 2021 The Authors. Movement Disorders Clinical Practice published by Wiley Periodicals LLC. on behalf of International Parkinson and Movement Disorder Society.

Déclaration de conflit d'intérêts

The authors report no sources of funding and no conflicts of interest.

Références

Orphanet J Rare Dis. 2015 Sep 26;10:123
pubmed: 26410222
Neuron. 2004 Jul 22;43(2):169-75
pubmed: 15260953
Neurology. 2020 Mar 31;94(13):e1378-e1385
pubmed: 32123049
Pediatr Neurol. 2000 Aug;23(2):134-41
pubmed: 11020638
Pediatr Neurol. 2017 Aug;73:101-105
pubmed: 28647130
PLoS One. 2015 May 21;10(5):e0127045
pubmed: 25996915
Dev Med Child Neurol. 1997 Apr;39(4):214-23
pubmed: 9183258
Brain. 2010 Dec;133(Pt 12):3598-610
pubmed: 20974617
Mult Scler. 2000 Jun;6(3):192-3
pubmed: 10871832
Epilepsia. 2015 Mar;56(3):422-30
pubmed: 25656163
Brain. 2007 Mar;130(Pt 3):828-35
pubmed: 17282997
Brain Dev. 2018 Mar;40(3):226-228
pubmed: 29269014
Mov Disord Clin Pract. 2017 Jan 05;4(3):406-411
pubmed: 30363489
Cogn Behav Neurol. 2018 Dec;31(4):214-219
pubmed: 30562231
Dev Med Child Neurol. 2015 Dec;57(12):1183-6
pubmed: 26400718
Neurology. 2019 Sep 24;93(13):e1248-e1259
pubmed: 31484714
Neurol Genet. 2017 Mar 02;3(2):e139
pubmed: 28293679
J Pediatr. 1993 May;122(5 Pt 1):673-9
pubmed: 8496742
Cold Spring Harb Mol Case Stud. 2016 Sep;2(5):a001008
pubmed: 27626066
Orphanet J Rare Dis. 2014 Jan 28;9:15
pubmed: 24468074
Dev Med Child Neurol. 2019 May;61(5):547-554
pubmed: 30362107
Brain Commun. 2021 Jun 04;3(3):fcab128
pubmed: 34396101
Mol Psychiatry. 2020 Apr;25(4):821-830
pubmed: 29895895

Auteurs

Marco Perulli (M)

Child Neurology and Psychiatry Unit Fondazione Policlinico Universitario Agostino Gemelli IRCCS Rome Italy.
Department of Neuroscience Catholic University Of The Sacred Heart Rome Italy.
Department of Clinical and Experimental Epilepsy UCL Queen Square Institute of Neurology London United Kingdom.

Josephine Poole (J)

Department of Clinical and Experimental Epilepsy UCL Queen Square Institute of Neurology London United Kingdom.

Giulia Di Lazzaro (G)

Department of Systems Medicine Tor Vergata University Rome Italy.
Neurology Unit Fondazione Policlinico Universitario Agostino Gemelli IRCCS Rome Italy.

Sasha D'Ambrosio (S)

Department of Clinical and Experimental Epilepsy UCL Queen Square Institute of Neurology London United Kingdom.
Dipartimento di Scienze Biomediche e Cliniche "L. Sacco" Università degli Studi di Milano Milan Italy.
Chalfont Centre for Epilepsy Bucks United Kingdom.

Katri Silvennoinen (K)

Department of Clinical and Experimental Epilepsy UCL Queen Square Institute of Neurology London United Kingdom.
Neuro Center Kuopio University Hospital Kuopio Finland.

Sara Zagaglia (S)

Department of Clinical and Experimental Epilepsy UCL Queen Square Institute of Neurology London United Kingdom.

Diego Jiménez-Jiménez (D)

Department of Clinical and Experimental Epilepsy UCL Queen Square Institute of Neurology London United Kingdom.
Chalfont Centre for Epilepsy Bucks United Kingdom.

Domenica Battaglia (D)

Child Neurology and Psychiatry Unit Fondazione Policlinico Universitario Agostino Gemelli IRCCS Rome Italy.
Department of Neuroscience Catholic University Of The Sacred Heart Rome Italy.

Sanjay M Sisodiya (SM)

Department of Clinical and Experimental Epilepsy UCL Queen Square Institute of Neurology London United Kingdom.
Chalfont Centre for Epilepsy Bucks United Kingdom.

Simona Balestrini (S)

Department of Clinical and Experimental Epilepsy UCL Queen Square Institute of Neurology London United Kingdom.
Chalfont Centre for Epilepsy Bucks United Kingdom.
Neuroscience Department Meyer Children Hospital Florence Italy.

Classifications MeSH